Pathogenesis of Graves' Ophthalmopathy
Author:
- Robert D. UtigerRURobert D. Utiger
- 25 June 1992
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 326 (26) , 1772-1773
Abstract
MOST physicians treat patients with hyperthyroidism caused by Graves' disease with either an antithyroid drug or radioactive iodine (iodine-131). Which treatment the physician recommends is based on factors such as the patient's age, the risk of side effects or later thyroid dysfunction, and the likelihood of remission. The report by Tallstedt et al. in this issue of the Journal 1 addresses another factor — the risk of ophthalmopathy after the treatment of hyperthyroidism.Most patients with Graves' hyperthyroidism have some ophthalmopathy, if only a few millimeters of exophthalmos and radiologic evidence of enlarged extraocular muscles. What are the risk factors for . . .Keywords
This publication has 10 references indexed in Scilit:
- Occurrence of Ophthalmopathy after Treatment for Graves' HyperthyroidismNew England Journal of Medicine, 1992
- Graves’ ophthalmopathy in relation to cigarette smoking and ethnic originClinical Endocrinology, 1992
- Thyroid Diseases after Treatment of Hodgkin's DiseaseNew England Journal of Medicine, 1991
- Thyroid-associated eye disease: pathophysiologyThe Lancet, 1991
- Administration of Thyroxine in Treated Graves' DiseaseNew England Journal of Medicine, 1991
- Current Trends in the Management of Graves' Disease*The Journal of Clinical Endocrinology & Metabolism, 1990
- Effect of abnormal thyroid function on the severity of Graves' ophthalmopathyArchives of internal medicine (1960), 1990
- More on smoking habits and Graves’ ophthalmopathyJournal of Endocrinological Investigation, 1989
- Treatment of Graves' disease and the course of ophthalmopathyThe American Journal of Medicine, 1989
- Studies on the occurrence of ophthalmopathy in Graves' diseaseEuropean Journal of Endocrinology, 1989